Resistance to New Antiretroviral Agents Session Posters
A molecular model of HIV-1 integrase
inhibitor resistance
D Hazuda
Novel
small-molecule compounds which inhibit strand transfer activity of HIV-1 integrase
W Sugiura
In vitro development of resistance
against styrylquinolines of HIV-1 by emergence of integrase mutations
A Chéret
Selection
for and characterization of HIV-1 isolates resistant to the maturation inhibitor
PA-457
C Wild
In vitro resistance profile of
small molecule HIV attachment inhibitors
PF Lin
In vitro escape of R5 primary
isolates from the CCR5 antagonist, UK-427,857, is difficult and involves continued
use of the CCR5 receptor
M Westby
Suppression of X4- and dual-tropic
HIV-1 variants during a short course of monotherapy with the CXCR4 antagonist
AMD3100
W Huang
A human monoclonal antibody blocks
HIV entry by a T20-like mechanism
MD Miller
Cross-resistance
profile of the novel lysine-containing HIV-1 protease inhibitor PL-100
G Sévigny
In
vitro selection and characterization of resistance to the new HIV protease inhibitor
GW640385
P Yates
Antiviral activity and resistance
profile of AG-001859, a novel HIV-1 protease inhibitor with potent activity
against protease inhibitor-resistant strains of HIV
J Hammond
Highly
potent HIV protease inhibitors with broad activity against MDR strains
SV Gulnik
In
vitro resistance development for a second-generation NNRTI: TMC125
G Heilek-Snyder
Dioxolane-thymine nucleoside (DOT)
against drug-resistant HIV-1 mutants and its molecular mechanism
CK Chu
Impact
of residue 50 substitutions on phenotypic susceptibility to protease inhibitors
DW Seekins